Marlene Debel Metlife Inc (MET) insider trading activity

Marlene Debel is EVP & Chief Risk Officer of METLIFE INC. Currently has a direct ownership of 108,507 shares of MET, which is worth approximately $8.51 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 2,741 shares (Common Stock) at a price of $69.73 per share, resulting in proceeds of $191,129. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K

0% 3M change

26.86% 12M change

Total Value Held $8.51 Million

MARLENE DEBEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	SELL Payment of exercise price or tax liability	$191,129 $69.73 p/Share	2,741 Reduced 2.46%	108,507 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$1,120,806 $69.16 p/Share	16,206 Reduced 12.72%	111,248 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	41,922 Added 24.75%	127,454 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	-	7,894 Added 8.45%	85,532 Common Stock
Aug 09 2023	SELL Open market or private sale	$593,323 $63.18 p/Share	9,391 Reduced 10.79%	77,638 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$492,631 $45.15 p/Share	10,911 Added 11.14%	87,029 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$181,595 $71.27 p/Share	2,548 Reduced 3.24%	76,118 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$1,030,616 $71.73 p/Share	14,368 Reduced 15.44%	78,666 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	37,735 Added 28.86%	93,034 Common Stock
Aug 19 2022	SELL Open market or private sale	$274,456 $67.6 p/Share	4,060 Reduced 6.84%	55,299 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	$171,730 $31.15 p/Share	5,513 Added 8.5%	59,359 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$116,701 $64.44 p/Share	1,811 Reduced 3.25%	53,846 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$282,598 $68.96 p/Share	4,098 Reduced 6.86%	55,657 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	16,643 Added 21.78%	59,755 Common Stock
May 11 2021	SELL Open market or private sale	$710,380 $64.58 p/Share	11,000 Reduced 20.33%	43,112 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$23,879 $58.96 p/Share	405 Reduced 0.74%	54,112 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$56,706 $59.44 p/Share	954 Reduced 1.72%	54,517 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$155,520 $57.43 p/Share	2,708 Reduced 4.65%	55,471 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	13,138 Added 18.42%	58,179 Common Stock
Mar 02 2020	SELL Payment of exercise price or tax liability	$56,145 $44.56 p/Share	1,260 Reduced 3.31%	36,766 Common Stock
Mar 02 2020	BUY Exercise of conversion of derivative security	-	3,704 Added 9.05%	37,220 Common Stock
Feb 25 2020	SELL Payment of exercise price or tax liability	$105,675 $47.58 p/Share	2,221 Reduced 6.08%	34,322 Common Stock
Feb 25 2020	BUY Grant, award, or other acquisition	-	6,458 Added 15.02%	36,543 Common Stock

Also insider at

RJF

RAYMOND JAMES FINANCIAL INC Financial Services

Director

Marlene Debel

EVP & Chief Risk Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MET shares.

Notify only if

Value

Insider Trading

Get notified when an Metlife Inc insider buys or sells MET shares.

Notify only if

Operation

Value

Type

News

Receive news related to METLIFE INC

Track Activities on MET

Account